They decorated DEX with an HCC-targeting peptide (P47-P), an AFP epitope (AFP212-A2), and a functional domain of high-mobility group nucleosome-binding protein 1 (N1ND-N) and demonstrated its potential for the individualized treatment of HCC via universal DEX vaccines (116). Here, AFP is linked to hepatocellular carcinoma.